Bausch & Lomb (BLCO) Total Current Liabilities (2021 - 2026)
Bausch & Lomb (BLCO) posted Total Current Liabilities of $1.8 billion for Q1 2026, down 5.21% on a QoQ basis from $1.9 billion in Q4 2025, and up 5.45% year-over-year from $1.7 billion in Q1 2025.
Bausch & Lomb (BLCO) Total Current Liabilities (2021 - 2026) Analysis & Trends
Bausch & Lomb's Total Current Liabilities history runs 6 years deep, the most recent figure standing at $1.8 billion for Q1 2026.
- Quarterly Total Current Liabilities rose 5.45% year-over-year to $1.8 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.8 billion (up 5.45% YoY) and the FY2025 annual result came in at $1.9 billion, up 10.47% from the prior year.
- Total Current Liabilities was $1.8 billion for Q1 2026 at Bausch & Lomb, down from $1.9 billion in the prior quarter.
- Across five years, Total Current Liabilities topped out at $1.9 billion in Q4 2025 and bottomed at $1.1 billion in Q1 2022.
- A 5-year average of $1.6 billion and a median of $1.6 billion in 2024 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2023 — Total Current Liabilities grew 4.08% — and 2024, when it gained 29.94%.
- Bausch & Lomb's Total Current Liabilities stood at $1.3 billion in 2022, then grew by 21.84% to $1.6 billion in 2023, then rose by 10.07% to $1.7 billion in 2024, then rose by 10.47% to $1.9 billion in 2025, then dropped by 5.21% to $1.8 billion in 2026.
- Business Quant data shows BLCO's Total Current Liabilities at $1.8 billion in Q1 2026, $1.9 billion in Q4 2025, and $1.9 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 3.00 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 1.92 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 8.51 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 2.54 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 1.35 Bn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 640.50 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 1.80 Bn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 3.35 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 1.91 Bn |
| 10 | Bausch & Lomb | 5.68 Bn | 5.47 Bn | 973.00 Mn | 1.82 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.82 Bn |
| Dec 31, 2025 | 1.92 Bn |
| Sep 30, 2025 | 1.90 Bn |
| Jun 30, 2025 | 1.84 Bn |
| Mar 31, 2025 | 1.73 Bn |
| Dec 31, 2024 | 1.74 Bn |
| Sep 30, 2024 | 1.80 Bn |
| Jun 30, 2024 | 1.68 Bn |
| Mar 31, 2024 | 1.62 Bn |
| Dec 31, 2023 | 1.58 Bn |
| Sep 30, 2023 | 1.39 Bn |
| Jun 30, 2023 | 1.33 Bn |
| Mar 31, 2023 | 1.25 Bn |
| Dec 31, 2022 | 1.30 Bn |
| Sep 30, 2022 | 1.20 Bn |
| Jun 30, 2022 | 1.27 Bn |
| Mar 31, 2022 | 1.09 Bn |
| Dec 31, 2021 | 1.10 Bn |